NDC 87625-113 - SurviveX Travel Med MOD
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 87625-113
- Manufacturer
- Intent Brands LLC
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SurviveX Travel Med MOD - Intent Brands LLC | Intent Brands LLC | 2026-08-04 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Childrens Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | CVS Pharmacy,Inc. | dbd8c221-8409-4851-a6b4-c9f5e8e346e7 | 2017-12-30 | Warnings | TC2D6JAD40 |
| Tukol A | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Genomma Lab USA, Inc. | 651f0d7c-c76b-434d-95fd-427609b40b46 | 2017-12-28 | Warnings | 04JA59TNSJ |
| EQUALINE regular strength antacid | ANTACID | SUPERVALU INC | 8091fc56-41b1-4f68-962a-534ecdb6f238 | 2017-12-27 | Warnings | H0G9379FGK |
| EQUALINE extra strength antacid | ANTACID | SUPERVALU INC | 8630a040-92ce-47a3-b1b3-888a58a9d457 | 2017-12-27 | Warnings | H0G9379FGK |
| Acetaminophen | ACETAMINOPHEN | Advance Pharmaceutical Inc. | 3793a17e-13bf-4d27-b8fa-6753b760f820 | 2017-12-22 | Warnings | 313782 362O9ITL9D |
| ACETAMINOPHEN PM | ACETAMINOPHEN PM | Advance Pharmaceutical Inc. | b172226e-8f2a-4d9c-b7c7-dd737b90463a | 2017-12-22 | Warnings | TC2D6JAD40 362O9ITL9D |
| ANTACID | CALCIUM CARBONATE | Advance Pharmaceutical Inc. | 0108b97f-02e9-4f86-9f33-cde4f919affd | 2017-12-22 | Warnings | H0G9379FGK |
| APAP | ACETAMINOPHEN | Advance Pharmaceutical Inc. | aba26f0a-94e4-4919-a3b0-033e3a9598ef | 2017-12-22 | Warnings | 362O9ITL9D |
| APAP | ACETAMINOPHEN | Advance Pharmaceutical Inc. | 5c75dc7f-06ae-440e-90ed-d7753eaa786e | 2017-12-22 | Warnings | 362O9ITL9D |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Advance Pharmaceutical Inc. | e1275cf5-94a7-4a15-be5c-81af95f8dd24 | 2017-12-22 | Warnings | TC2D6JAD40 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Advance Pharmaceutical Inc. | c80f9a4c-1055-45d2-8fde-5b57fad3c82a | 2017-12-22 | Warnings | 1049630 TC2D6JAD40 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Advance Pharmaceutical Inc. | 4e66c626-607f-4558-ab2e-2dd9a25f7be4 | 2017-12-22 | Warnings | TC2D6JAD40 |
| Pepto Relief | BISMUTH SUBSALICYLATE | Advance Pharmaceutical Inc. | a02babe7-9255-44c7-90e1-b5ad5e59c72a | 2017-12-22 | Warnings | 308761 62TEY51RR1 |
| Pep Tum | BISMUTH SUBSALICYLATE | First Aid Direct | bf966e9f-2f95-41cd-a6e5-b8eb521181d8 | 2017-12-22 | Warnings | M008 308761 62TEY51RR1 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc | 2017-12-13 | Warnings | 8MDF5V39QO |
| Extra Strength Antacid | CALCIUM CARBONATE | PuraCap Pharmaceutical LLC | 80509620-a3d1-49d5-b2e3-bff61ef4583d | 2017-12-13 | Warnings | H0G9379FGK |
| Extra Strength Antacid | CALCIUM CARBONATE | CVS PHARMACY, INC. | 80e10be2-879b-47ba-b34d-a3c25e838e05 | 2017-12-13 | Warnings | H0G9379FGK |
| Motion Sickness Relief | MECLIZINE HCL | CVS PHARMACY, INC. | eb137393-889c-4498-95cd-6c0e6e126c5f | 2017-11-28 | Warnings | HDP7W44CIO |
| Motion Sickness Relief | MECLIZINE HCL | PuraCap Pharmaceutical LLC | 8d772ff0-1476-48ca-a7e4-9473ce3db83a | 2017-11-28 | Warnings | HDP7W44CIO |
| Stomach Relief | BISMUTH SUBSALICYLATE | CVS PHARMACY, INC. | 65dbe287-4528-4dbd-9116-6d4812fd4fa2 | 2017-11-28 | Warnings | 308761 62TEY51RR1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.